Home > Insider Trading > Filing (0001209191-23-005717)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1204424	Lloyd Carney	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2023-01-30	1,376	$320.08	5,474	No	4	S	Direct
Common Stock	Disposition	2023-01-30	1,000	$320.70	4,474	No	4	S	Direct
Common Stock	Disposition	2023-01-30	324	$321.84	4,150	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Transaction made pursuant to Mr. Carney's company approved trading plan under Rule 10b5-1.
Mr. Carney undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $320.08 (range $319.40 to $320.38).
Open market sales reported on this line occurred at a weighted average price of $320.70 (range $320.43 to $321.31).
Open market sales reported on this line occurred at a weighted average price of $321.84 (range $321.54 to $322.23).